J B Chemicals and Pharmaceuticals Ltd
JBCHEPHARMJ B Chemicals and Pharmaceuticals Ltd
JBCHEPHARM
Price Chart
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| 47.74 | 9.37 | 0.59% |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 44.48 | 5.11 | 0.70% |
Forecast & Ratings
Detailed Forecastfrom 13 analysts
Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
J. B. Chemicals & Pharmaceuticals Limited manufactures and markets a range of pharmaceutical formulations, herbal remedies and active pharmaceutical ingredient (APIs).
Investor Presentation
View olderPeers
Compare with peersSun Pharmaceutical Industries Ltd
Cipla Ltd
Dr Reddy's Laboratories Ltd
Mankind Pharma Ltd
Torrent Pharmaceuticals Ltd
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
All values in ₹
All values in ₹
Revenue Forecast
All values in ₹ Thousand cr.
All values in ₹ Thousand cr.
Earnings Per Share Forecast
All values in ₹
All values in ₹
Income
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2015 | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 1,155.10 | 1,268.43 | 1,394.45 | 1,445.49 | 1,684.64 | 1,825.40 | 2,154.90 | 2,463.47 | 3,159.22 | 3,353.97 | ||||||||||
Raw Materials | 465.80 | 483.71 | 519.54 | 544.41 | 615.76 | 634.79 | 742.76 | 860.38 | 1,179.20 | 2,518.91 | ||||||||||
| Power & Fuel Cost | 53.02 | 55.28 | 54.89 | 58.28 | 63.29 | 61.54 | 62.60 | 71.47 | 91.54 | |||||||||||
| Employee Cost | 159.56 | 175.31 | 217.34 | 251.10 | 288.18 | 322.92 | 340.60 | 439.24 | 543.45 | |||||||||||
| Selling & Administrative Expenses | 176.18 | 157.42 | 174.28 | 205.31 | 234.51 | 228.72 | 233.56 | 358.90 | 448.81 | |||||||||||
| Operating & Other expenses | 109.53 | 132.62 | 145.85 | 131.98 | 135.62 | 159.19 | 102.59 | 150.79 | 190.53 | |||||||||||
EBITDA | 191.01 | 264.09 | 282.55 | 254.41 | 347.28 | 418.24 | 672.79 | 582.69 | 705.69 | 835.06 | ||||||||||
| Depreciation/Amortization | 38.64 | 41.22 | 47.22 | 56.97 | 55.64 | 66.32 | 68.67 | 72.66 | 114.41 | 123.75 | ||||||||||
| PBIT | 152.37 | 222.87 | 235.33 | 197.44 | 291.64 | 351.92 | 604.12 | 510.03 | 591.28 | 711.31 | ||||||||||
| Interest & Other Items | 6.82 | 10.65 | 5.37 | 3.49 | 4.65 | 3.03 | 7.24 | 5.12 | 36.05 | 44.69 | ||||||||||
| PBT | 145.55 | 212.22 | 229.96 | 193.95 | 286.99 | 348.89 | 596.88 | 504.91 | 555.23 | 666.62 | ||||||||||
| Taxes & Other Items | 45.15 | 49.68 | 45.88 | 55.61 | 93.52 | 76.85 | 148.92 | 119.54 | 145.40 | 179.98 | ||||||||||
| Net Income | 100.40 | 162.54 | 184.08 | 138.34 | 193.47 | 272.04 | 447.96 | 385.37 | 409.83 | 486.64 | ||||||||||
| EPS | 5.92 | 9.58 | 10.85 | 8.22 | 11.81 | 17.27 | 28.98 | 24.93 | 26.50 | 31.45 | ||||||||||
| DPS | 7.00 | 2.50 | 0.50 | 1.00 | 2.50 | 5.50 | 8.25 | 8.25 | 8.88 | 8.88 | ||||||||||
| Payout ratio | 1.18 | 0.26 | 0.05 | 0.12 | 0.21 | 0.32 | 0.28 | 0.33 | 0.33 | 0.28 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFInvestor Presentation
Peers & Comparison
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| J B Chemicals and Pharmaceuticals Ltd | 56.69 | 9.37 | 0.59% |
| Sun Pharmaceutical Industries Ltd | 35.09 | 5.01 | 0.93% |
| Cipla Ltd | 35.23 | 4.16 | 0.69% |
| Dr Reddy's Laboratories Ltd | 21.37 | 4.14 | 0.69% |
Price Comparison
Compare JBCHEPHARM with any stock or ETFShareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Total Retail Holding
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2022
Mar 2023
Jun 2023
Sep 2023
Shareholding History
Mutual Funds Holding Trend
Mutual Fund Holding
In last 3 months, mutual fund holding of the company has almost stayed constant
Top 5 Mutual Funds holding J B Chemicals and Pharmaceuticals Ltd
| Funds (Top 5) | The rupee value of the stock held by the fund divided by the stock’s market cap Market-cap held | Percentage of the fund’s portfolio invested in the stock Weight | Change in the portfolio weight of the stock over the last 3 months 3M holding change | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months Portfolio rank(3M change) |
|---|---|---|---|---|
NIPPON INDIA FLEXICAP FUND-DIRECT PLAN-GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.3040% | Percentage of the fund’s portfolio invested in the stock 1.46% | Change in the portfolio weight of the stock over the last 3 months -0.08% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 15/90 (+1) |
Axis Multicap Fund - Direct Growth Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.2493% | Percentage of the fund’s portfolio invested in the stock 1.36% | Change in the portfolio weight of the stock over the last 3 months 0.18% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 43/68 (0) |
KOTAK MULTICAP FUND - DIRECT PLAN - GROWTH Growth | The rupee value of the stock held by the fund divided by the stock’s market cap 0.2161% | Percentage of the fund’s portfolio invested in the stock 0.79% | Change in the portfolio weight of the stock over the last 3 months -0.01% | The rank of the stock in the fund’s portfolio based on its weight in the portfolio along with the change in the rank over the last 3 months 62/75 (-32) |
Compare 3-month MF holding change on Screener
smallcases
A smallcase is a basket of stocks/ETFs that represents an idea or theme.Diversify your risk and buy smallcases that have J B Chemicals and Pharmaceuticals Ltd
Events
Dividend Trend
No Dividend Cuts
JBCHEPHARM has increased or maintained dividend levels over the last 5 years
Dividend Yield
Current dividend yield is 0.60%. An investment of ₹1,000 in the stock is expected to generate dividend of ₹6.00 every year
Dividends
Corp. Actions
Announcements
Legal Orders
Upcoming Dividends
No upcoming dividends are available
Past Dividends
Cash Dividend
Ex DateEx DateAug 17, 2023
Dividend/Share
₹9.25
Ex DateEx Date
Aug 17, 2023
Cash Dividend
Ex DateEx DateFeb 17, 2023
Dividend/Share
₹8.50
Ex DateEx Date
Feb 17, 2023
Cash Dividend
Ex DateEx DateAug 12, 2022
Dividend/Share
₹8.00
Ex DateEx Date
Aug 12, 2022
Cash Dividend
Ex DateEx DateFeb 23, 2022
Dividend/Share
₹8.50
Ex DateEx Date
Feb 23, 2022
Cash Dividend
Ex DateEx DateSep 1, 2021
Dividend/Share
₹8.00
Ex DateEx Date
Sep 1, 2021
News & Opinions
India Pharma - IPM Growth On Moderate Uptrend In September: Motilal Oswal
1 month ago•Bloomberg Quint
4+1 stocks that Dipan Mehta would keep in his 5-year-plus basket
3 months ago•Economic Times
JB Chemicals gets USFDA nod to market generic medication
3 months ago•Economic Times
JB Chemicals scales 52-week high on 35% surge in Q1 net profit
3 months ago•Moneycontrol
JB Chemicals - Normalised Growth To Dampen Earnings Flare Up; Downgrade To ‘Reduce’: Yes Securities
5 months ago•Bloomberg Quint
JB Chemicals shares hit record high as Jefferies values stock at 15% premium over Torrent Pharma
5 months ago•Business Today
JB Chemicals hits record high as Jefferies initiates coverage with ‘buy’ call
5 months ago•Moneycontrol
Higher than Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 16.93%, vs industry avg of 8.45%
Increasing Market Share
Over the last 5 years, market share increased from 0.71% to 0.99%
Higher than Industry Net Income
Over the last 5 years, net income has grown at a yearly rate of 24.26%, vs industry avg of 9.82%